Bansi Desai
Stock Analyst at J.P. Morgan
(2.04)
# 3,102
Out of 4,423 analysts
64
Total ratings
34.9%
Success rate
0.9%
Average return
Main Sectors:
Stocks Rated by Bansi Desai
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NSE: ALKEM Alkem Laboratories Limited | Maintained: Hold | ₹6,400 → ₹5,900 | $5,373.50 | +9.80% | 5 | May 29, 2026 | |
| NSE: BLUEJET Blue Jet Healthcare Limited | Maintained: Sell | ₹600.00 → ₹370.00 | $512.60 | -27.82% | 4 | May 27, 2026 | |
| NSE: FORTIS Fortis Healthcare Limited | Maintained: Buy | ₹1,050 → ₹1,120 | $962.95 | +16.31% | 5 | May 27, 2026 | |
| NSE: DIVISLAB Divi's Laboratories Limited | Maintained: Buy | ₹7,800 → ₹7,400 | $6,743.00 | +9.74% | 2 | May 25, 2026 | |
| NSE: MANKIND Mankind Pharma Limited | Maintained: Buy | ₹2,800 → ₹2,850 | $2,414.20 | +18.05% | 6 | May 22, 2026 | |
| NSE: ZYDUSLIFE Zydus Lifesciences Limited | Maintained: Hold | ₹1,010 → ₹1,050 | $1,070.80 | -1.94% | 4 | May 22, 2026 | |
| NSE: ANTHEM Anthem Biosciences Limited | Maintained: Buy | ₹780.00 → ₹850.00 | $791.05 | +7.45% | 3 | May 22, 2026 | |
| NSE: CIPLA Cipla Limited | Maintained: Buy | ₹1,780 → ₹1,550 | $1,351.80 | +14.66% | 5 | May 18, 2026 | |
| NSE: LUPIN Lupin Limited | Maintained: Buy | ₹2,550 → ₹2,600 | $2,352.30 | +10.53% | 5 | Nov 9, 2025 | |
| NSE: DRREDDY Dr. Reddy's Laboratories Limited | Maintained: Sell | ₹1,090 → ₹1,150 | $1,272.10 | -9.60% | 4 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹34,500 → ₹37,000 | $26,215.00 | +41.14% | 5 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹1,350 → ₹1,550 | $1,782.00 | -13.02% | 3 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹1,240 → ₹1,480 | $1,265.80 | +16.92% | 2 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹2,030 → ₹1,970 | $1,838.30 | +7.16% | 4 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹1,700 → ₹1,840 | $1,470.80 | +25.10% | 4 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹1,390 → ₹1,325 | $1,094.75 | n/a | 2 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹8,800 | $8,489.50 | n/a | 1 | Feb 12, 2025 |
Alkem Laboratories Limited
May 29, 2026
Maintained: Hold
Price Target: ₹6,400 → ₹5,900
Current: $5,373.50
Upside: +9.80%
Blue Jet Healthcare Limited
May 27, 2026
Maintained: Sell
Price Target: ₹600.00 → ₹370.00
Current: $512.60
Upside: -27.82%
Fortis Healthcare Limited
May 27, 2026
Maintained: Buy
Price Target: ₹1,050 → ₹1,120
Current: $962.95
Upside: +16.31%
Divi's Laboratories Limited
May 25, 2026
Maintained: Buy
Price Target: ₹7,800 → ₹7,400
Current: $6,743.00
Upside: +9.74%
Mankind Pharma Limited
May 22, 2026
Maintained: Buy
Price Target: ₹2,800 → ₹2,850
Current: $2,414.20
Upside: +18.05%
Zydus Lifesciences Limited
May 22, 2026
Maintained: Hold
Price Target: ₹1,010 → ₹1,050
Current: $1,070.80
Upside: -1.94%
Anthem Biosciences Limited
May 22, 2026
Maintained: Buy
Price Target: ₹780.00 → ₹850.00
Current: $791.05
Upside: +7.45%
Cipla Limited
May 18, 2026
Maintained: Buy
Price Target: ₹1,780 → ₹1,550
Current: $1,351.80
Upside: +14.66%
Lupin Limited
Nov 9, 2025
Maintained: Buy
Price Target: ₹2,550 → ₹2,600
Current: $2,352.30
Upside: +10.53%
Dr. Reddy's Laboratories Limited
Aug 19, 2025
Maintained: Sell
Price Target: ₹1,090 → ₹1,150
Current: $1,272.10
Upside: -9.60%
Aug 15, 2025
Maintained: Buy
Price Target: ₹34,500 → ₹37,000
Current: $26,215.00
Upside: +41.14%
Aug 11, 2025
Maintained: Hold
Price Target: ₹1,350 → ₹1,550
Current: $1,782.00
Upside: -13.02%
Aug 11, 2025
Maintained: Hold
Price Target: ₹1,240 → ₹1,480
Current: $1,265.80
Upside: +16.92%
Aug 1, 2025
Maintained: Buy
Price Target: ₹2,030 → ₹1,970
Current: $1,838.30
Upside: +7.16%
Jul 29, 2025
Maintained: Buy
Price Target: ₹1,700 → ₹1,840
Current: $1,470.80
Upside: +25.10%
May 22, 2025
Maintained: Buy
Price Target: ₹1,390 → ₹1,325
Current: $1,094.75
Upside: n/a
Feb 12, 2025
Maintained: Buy
Price Target: ₹8,800
Current: $8,489.50
Upside: n/a